Stock comparison
Hologic
LeMaitre Vascular
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
HOLX
Hologic
Market cap
$16.97B
Sector
Healthcare
LMAT
LeMaitre Vascular
Market cap
$2.23B
Sector
Healthcare
Overall winner
LeMaitre Vascular LMAT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | HOLX | LMAT | Winner |
|---|---|---|---|
| Warren Buffett | 55C | 77B | LMAT |
| Benjamin Graham | 85A | 89A | LMAT |
| Philip Fisher | 42D | 81C | LMAT |
| Peter Lynch | 22F | 67B | LMAT |
| Joel Greenblatt | 45D | 56D | LMAT |
| Charlie Munger | 52C | 68D | LMAT |
| Terry Smith | 52D | 69D | LMAT |
Side-by-side metrics
| Metric | HOLX | LMAT |
|---|---|---|
| Market cap | $16.97B | $2.23B |
| P/E (TTM) | 31.4x | 37.1x |
| EV/EBIT | 24.2x | 36.6x |
| ROIC (TTM) | 7.18% | 9.43% |
| Gross margin | 52.82% | 72.39% |
| Net margin | 13.18% | 24.35% |
| Revenue CAGR 5y | -7.63% | 12.75% |
| EPS CAGR 5y | -23.45% | 19.04% |
| Debt / Equity | 0.5x | 0.5x |
| Dividend yield | 0.0% | 0.84% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
HOLX leads on
- Market cap$16.97Bvs $2.23B+87%
- EV/EBIT24.2xvs 36.6x+34%
- P/E (TTM)31.4xvs 37.1x+16%
LMAT leads on
- EPS CAGR 5y19.04%vs -23.45%+181%
- Revenue CAGR 5y12.75%vs -7.63%+160%
- Dividend yield0.84%vs 0.0%+100%
- Net margin24.35%vs 13.18%+46%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.